Gregg L. Semenza

Gregg Leonard Semenza (born July 1, 1956) is an American professor of pediatrics, radiation oncology, biological chemistry, medicine, and oncology at the Johns Hopkins University School of Medicine. He is the director of the vascular program at the Institute for Cell Engineering.[1] He is a 2016 recipient of the Lasker Award for Basic Medical Research.[2] He is known for his discovery of HIF-1, which allows cancer cells to adapt to oxygen-poor environments. Semenza was born in New York City.

Semenza received the 2019 Nobel Prize in Physiology or Medicine for "discoveries of how cells sense and adapt to oxygen availability" with William Kaelin Jr. and Peter J. Ratcliffe.[3]

References
  1. "Gregg L. Semenza, M.D., Ph.D."
  2. Foundation, Lasker. "Oxygen sensing – an essential process for survival - The Lasker Foundation". The Lasker Foundation.
  3. "The Nobel Prize in Physiology or Medicine 2019". NobelPrize.org. Retrieved 2019-10-07.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.